Serial #79137943
LIVE

Serial Number

79137943

Owner

MyMedsandMe Limited

Filing Date

Jul 25, 2013

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79137943 Trademark

Serial Number: 79137943 • Registration: 4513199

Serial #79137943 is a trademark filed by MyMedsandMe Limited on July 25, 2013. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MyMedsandMe Limited (4 trademarks)

2 Crossways Business Centre
Aylesbury, HP18 0RA , GB

Entity Type: 99

Trademark Details

Filing Date

July 25, 2013

Registration Date

April 15, 2014

Published for Opposition

January 28, 2014

Cancellation Date

July 24, 2023

Goods & Services

Computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information; computer software for capturing and providing information concerning quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said quality, reactions and events and producing reports regarding such quality, reactions and events; computer programs for capturing and providing information concerning quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said quality, reactions and events and for producing reports regarding such quality, reactions and events, computer software applications for capturing information concerning quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; computer software for the evaluation and analysis of data and information concerning the quality of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication and/or pharmaceuticals

Telecommunications services, namely, transmission of data by means of telecommunications networks, wireless communication networks and the Internet; telecommunication services for providing multiple user access to a global network; transfer of data by telecommunications; transmission and reception of database information via telecommunications networks; data transmission and reception services via telecommunications means; providing telecommunications connections to databases; electronic exchange of data stored in databases accessible via telecommunication networks; communication services, namely, providing electronic transmission of information stored in a database via interactively communicating computer systems; providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; information transmission via electronic communications networks; providing multiple user access to proprietary collections of information by means of global computer information networks; telecommunications services, namely, electronic exchange of medical records between patients or health care professionals and pharmaceutical companies; telecommunication services, namely, providing access to an electronic exchange of medical records between patients or health care professionals and pharmaceutical companies

Software as a service (SAAS) services featuring software for capturing and providing data concerning quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; software as a service (SAAS) services featuring software for evaluating and analyzing data and information concerning the quality of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication or pharmaceuticals; providing temporary use of on-line non-downloadable software which enables the capture of information concerning quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and/or pharmaceuticals, which enables follow-up questions and answers regarding said quality, reactions and events and which enables the production of reports regarding said reactions and events; services for maintenance of computer software; providing temporary use of non-downloadable software allowing web site users to send and receive information concerning quality of medication and/or pharmaceuticals used, reactions and events resulting form the use of medication and/or pharmaceuticals, answer and read answers to follow-up questions regarding said quality, reactions and events and produce reports regarding said reactions and events; software as a service (SAAS) services featuring software for collecting, evaluating and analyzing data; design of computer software for reporting reactions and events resulting from the use of medication and/or pharmaceuticals; design of computer software for commercial analysis and reporting

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 17, 2024 DENC
DEATH OF INTERNATIONAL REGISTRATION
Feb 17, 2024 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Apr 17, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 11, 2022 INTS
INVALIDATION PROCESSED
Mar 10, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
CANCELLED SECTION 71
Feb 26, 2021 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 15, 2019 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 1, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 16, 2014 FICS
FINAL DISPOSITION PROCESSED
Jul 16, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 15, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 15, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jan 28, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Jan 25, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 8, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 8, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 8, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 26, 2013 PREV
ASSIGNED TO LIE
Dec 26, 2013 ALIE
REFUSAL PROCESSED BY IB
Dec 3, 2013 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 3, 2013 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 18, 2013 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 18, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 18, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2013 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 13, 2013 RFCS
REFUSAL PROCESSED BY MPU
Nov 12, 2013 RFRR
APPLICATION FILING RECEIPT MAILED
Nov 12, 2013 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 9, 2013 RFCR
NON-FINAL ACTION WRITTEN
Nov 8, 2013 CNRT
ASSIGNED TO EXAMINER
Nov 7, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2013 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 4, 2013 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 1, 2013 REPR